Literature DB >> 12639965

Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3.

Kylie A Hotchkiss1, Anthony W Ashton, Edward L Schwartz.   

Abstract

Thymidine phosphorylase is an angiogenic factor that is frequently overexpressed in solid tumors, in rheumatoid arthritis, and in response to inflammatory cytokines. Our previous studies showed that cells expressing thymidine phosphorylase stimulated endothelial cell migration in vitro. This was a consequence of the intracellular metabolism of thymidine by thymidine phosphorylase and subsequent extracellular release of 2-deoxyribose. The mechanisms by which 2-deoxyribose might mediate thymidine phosphorylase-induced cell migration in vitro, however, are obscure. Here we show that both thymidine phosphorylase and 2-deoxyribose stimulated the formation of focal adhesions and the tyrosine 397 phosphorylation of focal adhesion kinase in human umbilical vein endothelial cells. Although similar actions occurred upon treatment with the angiogenic factor vascular endothelial growth factor (VEGF), thymidine phosphorylase differed from VEGF in that its effect on endothelial cell migration was blocked by antibodies to either integrin alpha 5 beta 1 or alpha v beta 3, whereas VEGF-induced endothelial cell migration was only blocked by the alpha v beta 3 antibody. Further, thymidine phosphorylase and 2-deoxyribose, but not VEGF, increased the association of both focal adhesion kinase and the focal adhesion-associated protein vinculin with integrin alpha 5 beta 1 and, in intact cells, increased the co-localization of focal adhesion kinase with alpha 5 beta 1. Thymidine phosphorylase and 2-deoxyribose-induced focal adhesion kinase phosphorylation was blocked by the antibodies to alpha 5 beta 1 and alpha v beta 3, directly linking the migration and signaling components of thymidine phosphorylase and 2-deoxyribose action. Cell surface expression of alpha 5 beta 1 was also increased by thymidine phosphorylase and 2-deoxyribose. These experiments are the first to demonstrate a direct effect of thymidine phosphorylase and 2-deoxyribose on signaling pathways associated with endothelial cell migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639965     DOI: 10.1074/jbc.M212670200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells.

Authors:  A Rajakumar; T Chu; D E Handley; K D Bunce; B Burke; C A Hubel; A Jeyabalan; D G Peters
Journal:  Placenta       Date:  2010-11-13       Impact factor: 3.481

Review 2.  TAS-102, a novel antitumor agent: a review of the mechanism of action.

Authors:  Heinz-Josef Lenz; Sebastian Stintzing; Fotios Loupakis
Journal:  Cancer Treat Rev       Date:  2015-06-06       Impact factor: 12.111

3.  Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration.

Authors:  Jian Zhou; Yong-Sheng Xiao; Zhao-You Tang; Jia Fan; Zhi-Quan Wu; Yan Zhao; Qiong Xue; Zao-Zhuo Shen; Yin-Kun Liu; Sheng-Long Ye
Journal:  J Cancer Res Clin Oncol       Date:  2005-04-30       Impact factor: 4.553

4.  P2Y2 nucleotide receptor activation enhances the aggregation and self-organization of dispersed salivary epithelial cells.

Authors:  Farid G El-Sayed; Jean M Camden; Lucas T Woods; Mahmoud G Khalafalla; Michael J Petris; Laurie Erb; Gary A Weisman
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-23       Impact factor: 4.249

5.  Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase.

Authors:  Phillip A Schwartz; Mathew J Vetticatt; Vern L Schramm
Journal:  Biochemistry       Date:  2011-02-03       Impact factor: 3.162

6.  Trifluridine/Tipiracil (Lonsurf) for the Treatment of Metastatic Colorectal Cancer.

Authors:  Troy Kish; Priyasha Uppal
Journal:  P T       Date:  2016-05

7.  Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma.

Authors:  Jongkonnee Thanasai; Temduang Limpaiboon; Patcharee Jearanaikoon; Banchob Sripa; Chawalit Pairojkul; Srisurang Tantimavanich; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

8.  Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.

Authors:  Luciane Rostirola Cavazzola; Gustavo Franco Carvalhal; Candida Deves; Daiana Renck; Ricardo Almeida; DIóGENES Santiago Santos
Journal:  Oncol Lett       Date:  2015-04-01       Impact factor: 2.967

9.  Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate.

Authors:  Dina S Vara; Michelangelo Campanella; Ilaria Canobbio; Warwick B Dunn; Giuseppe Pizzorno; Michio Hirano; Giordano Pula
Journal:  Thromb Haemost       Date:  2013-03-14       Impact factor: 5.249

10.  Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap.

Authors:  Haiyan Lu; Robert S Klein; Edward L Schwartz
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.